Mekesha Senter, NP
Nurse Practitioner · Wilkesboro, NCNPI 1679114953
Payments from drug & device makers
Across 444 payments — averaging $15.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novo Nordisk$994
- Pfizer$849
- Lilly USA, LLC$686
- AstraZeneca$634
- Boehringer Ingelheim$478
- plus $2K from 26 others
What the payments were for
- Food & beverage$6,93899%
- Education$851%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 79 | $1,059 |
| Novo Nordisk | 71 | $994 |
| Pfizer | 56 | $849 |
| Lilly USA, LLC | 45 | $686 |
| AstraZeneca | 32 | $634 |
| Boehringer Ingelheim | 23 | $478 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 13 | $366 |
| Abbott | 14 | $330 |
| Amgen | 19 | $235 |
| Novartis | 10 | $191 |
| GSK | 11 | $178 |
| Kowa Pharmaceuticals America, Inc. | 20 | $155 |
| Astellas Pharma US Inc | 3 | $116 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $115 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $102 |
| Sunovion Pharmaceuticals Inc. | 6 | $89 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $59 |
| Sumitomo Pharma America, Inc. | 4 | $59 |
| Baxter Healthcare | 2 | $51 |
| Corium, LLC | 3 | $37 |
| Bayer | 2 | $34 |
| Exact Sciences | 2 | $33 |
| Shield Therapeutics Inc | 2 | $32 |
| Merck | 1 | $19 |
| Viatris Specialty LLC | 1 | $18 |
| Inspire Medical Systems, Inc. | 1 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Paratek Pharmaceuticals, Inc. | 1 | $15 |
| Eisai Inc. | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Alkermes, Inc. | 1 | $13 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
How this compares
$7,023 in reported general payments places this provider in the 95th percentile of 4,393 nurse practitioner providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 127 | $138,051 |
| OzempicSemaglutide | 73 | $108,211 |
| JardianceEmpagliflozin | 75 | $70,206 |
| TrulicityDulaglutide | 32 | $39,310 |
| FarxigaDapagliflozin Propanediol | 30 | $36,548 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 23 | $25,710 |
| JanuviaSitagliptin Phosphate | 18 | $20,667 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 31 | $19,508 |
| EliquisApixaban | 21 | $15,514 |
| LivaloPitavastatin Calcium | 21 | $14,802 |
| Breo ElliptaFluticasone/Vilanterol | 30 | $14,065 |
| Dexlansoprazole DrDexlansoprazole | 34 | $12,993 |
| LinzessLinaclotide | 15 | $11,930 |
| Repatha SureclickEvolocumab | 12 | $7,263 |
| Novolog Mix 70-30Insulin Aspart Prot/Insuln Asp | 14 | $4,868 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $686 | $177,362159 claims |
| Novo NordiskOzempic, Novolog Mix 70-30 | $994 | $113,08087 claims |
| Boehringer IngelheimJardiance | $478 | $70,20675 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $634 | $66,45471 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $178 | $33,57361 claims |
| MerckJanuvia | $19 | $20,66718 claims |
| PfizerEliquis | $849 | $15,51421 claims |
| Kowa Pharmaceuticals America, Inc.Livalo | $155 | $14,80221 claims |
| AbbVieLinzess, Synthroid | $1,059 | $14,68537 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,393 nurse practitioner providers in North Carolina.
Other nurse practitioner in Wilkesboro
- Sandrivette JohnsonRaleigh$573K
- Skyler RogersPinehurst$174K
- Jamie DinerDurham$170K
- Ayeshia WrightMocksville$145K
- Deborah AllenDurham$112K
- Jeanann VawterGastonia$97K
- Terra KampJacksonville$72K
- Mary DilorenzoCharlotte$71K
- Olivia OgburnWinston Salem$70K
- Bridget ArchambaultDurham$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.